355 related articles for article (PubMed ID: 21239242)
1. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
3. Outcome of breast cancer screening in Denmark.
Lynge E; Bak M; von Euler-Chelpin M; Kroman N; Lernevall A; Mogensen NB; Schwartz W; Wronecki AJ; Vejborg I
BMC Cancer; 2017 Dec; 17(1):897. PubMed ID: 29282034
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
5. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
[TBL] [Abstract][Full Text] [Related]
6. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
7. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
8. Digital mammography screening: weighing reduced mortality against increased overdiagnosis.
de Gelder R; Fracheboud J; Heijnsdijk EA; den Heeten G; Verbeek AL; Broeders MJ; Draisma G; de Koning HJ
Prev Med; 2011 Sep; 53(3):134-40. PubMed ID: 21718717
[TBL] [Abstract][Full Text] [Related]
9. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
10. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
11. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
Andersen SB; Vejborg I; von Euler-Chelpin M
Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
[TBL] [Abstract][Full Text] [Related]
12. Potential impact of USPSTF recommendations on early diagnosis of breast cancer.
Aragon R; Morgan J; Wong JH; Lum S
Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591
[TBL] [Abstract][Full Text] [Related]
13. Predicting the risk of a false-positive test for women following a mammography screening programme.
Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
[TBL] [Abstract][Full Text] [Related]
14. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
15. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
16. MRI of the breast as part of the assessment in population-based mammography screening.
Bick U; Engelken F; Diederichs G; Dzyuballa R; Ortmann M; Fallenberg EM
Rofo; 2013 Sep; 185(9):849-56. PubMed ID: 23740312
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Møller P; Stormorken A; Jonsrud C; Holmen MM; Hagen AI; Clark N; Vabø A; Sun P; Narod SA; Mæhle L
Breast Cancer Res Treat; 2013 May; 139(1):155-61. PubMed ID: 23615785
[TBL] [Abstract][Full Text] [Related]
18. Breast MRI: opportunities and challenges.
Day D
Minn Med; 2009 Dec; 92(12):45-8. PubMed ID: 20092173
[TBL] [Abstract][Full Text] [Related]
19. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
20. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]